Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
44
datasets available to search
ShareScore release 0.9.0
Dataset results
44 results for “Rituxan”
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
ClinicalTrials.gov study NCT01278745. IPD Sharing: Not stated. Countries: 1. Publications: 1.
GP2013 Treatment in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan® or MabThera®
ClinicalTrials.gov study NCT02514772. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid Arthritis
ClinicalTrials.gov study NCT00298272. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Higher Dose of Rituxan Versus Standard Doses of Rituxan With Cyclophosphamide, Vincristine, and Prednisone in Subjects With Chronic ITP
ClinicalTrials.gov study NCT00774202. IPD Sharing: YES. Countries: 1. Publications: 1.
Trial of VELCADE and Rituxan as Front-line Tx for Low-grade NHL
ClinicalTrials.gov study NCT00369707. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Lenalidomide Plus Rituxan for Untreated Mantle Cell Lymphoma
ClinicalTrials.gov study NCT01472562. IPD Sharing: Not stated. Countries: 1. Publications: 3.
To Compare Efficacy and Safety Between CT-P10 and Rituxan in Patients With Low Tumour Burden Follicular Lymphoma
ClinicalTrials.gov study NCT02260804. IPD Sharing: NO. Countries: 1. Publications: 2.
Rituxan in Churg Strauss Syndrome With Renal Involvement
ClinicalTrials.gov study NCT00424749. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase 2 Clinical Trial of Rituxan and B-Glucan PGG in Relapsed Indolent Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02086175. IPD Sharing: YES. Countries: 1. Publications: 0.
Treatment of Relapsed Low-Grade or Follicular Lymphoma With Rituximab (Also Known as Rituxan, IDEC-C2B8, IDEC-102)
ClinicalTrials.gov study NCT00168740. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Pilot Trial of Rituxan in Refractory Myasthenia Gravis
ClinicalTrials.gov study NCT00619671. IPD Sharing: Not stated. Countries: 1. Publications: 23.
Safety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00048555. IPD Sharing: Not stated. Countries: 1. Publications: 1.
To Demonstrate Equivalence of Pharmacokinetics and Noninferiority of Efficacy for CT-P10 in Comparison With Rituxan
ClinicalTrials.gov study NCT02162771. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Safety Study of Rituximab (Rituxan®) in Chronic Urticaria
ClinicalTrials.gov study NCT00216762. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular Lymphoma
ClinicalTrials.gov study NCT00177554. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Trial of Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD) in Patients With Relapsed Non-Hodgkins Lymphoma
ClinicalTrials.gov study NCT00166439. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of the Safety and Efficacy of Nipent, Cytoxan, and Rituxan
ClinicalTrials.gov study NCT00496873. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Moxetumomab Pasudotox-tdfk (Lumoxiti(TM)) and Either Rituximab (Rituxan(R)) or Ruxience for Relapsed Hairy Cell Leukemia
ClinicalTrials.gov study NCT03805932. IPD Sharing: YES. Countries: 1. Publications: 0.
Rituxan + BEAM and Auto Stem Cell Transplant for High Risk Lymphoma or Hodgkin's Disease
ClinicalTrials.gov study NCT01702961. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas
ClinicalTrials.gov study NCT00184002. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.